AbbVie, the biopharmaceutical company, has acquired Allergan in what its CEO described as an “important milestone”.
The acquisition includes Allergan’s global aesthetics
The acquisition will see AbbVie achieve approximately US$30bn in full-year 2020 revenues
AbbVie, the biopharmaceutical company, has acquired Allergan in what its CEO described as an “important milestone”.
The acquisition includes Allergan’s global aesthetics